Income, treatment patterns and outcome in patients with stage IV colorectal cancer
European Journal of Cancer · 2026
DOI: 10.1016/j.ejca.2026.116732 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Laskarina J K Galanos und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands; Department of Surgery, Catharina Hos…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Income. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: This study explores the association between income and patient- and treatment characteristics, diagnosis through screening and survival of patients with synchronous metastasized CRC. METHODS: Patients diagnosed with stage IV CRC between 2015 and 2023 were selected from the Netherlands Cancer Registry. Income at postal code level was used (Statistics Netherlands). Multivariable logistic regression analyses were used to determine the association between income and treatment. Crude relative survival stratified for income was calculated, as well as relative excess risks of death using a multivariable generalized linear model. RESULTS: The study included 24,666 patients, with respectively 33%, 35% and 32% having higher, intermediate and lower income. Detection through screening was more often realized in the higher income group compared to intermediate and lower income (9% vs. 8% vs.6%, p < 0.001). Among patients with single-organ metastases, higher income patients were more often treated with curative intent for metastases to the liver (40% vs. 35% vs. 29%, p < 0.001) and peritoneum (36% vs. 29% vs.22%, p < 0.001) compared to intermediate or lower income, also in multivariable analyses. Similarly, systemic therapy was given more frequently to patients with higher income than those with intermediate or lower income (56% vs. 51% vs.42%, p < 0.001). Crude 3-year relative survival was 21% (lower), 22% (intermediate) and 26% (higher income, adjusted RER higher vs. lower income: 0.93, [95%CI 0.90-0.97]; intermediate vs. lower income: 0.95, [95%CI 0.92-0.99]). CONCLUSIONS: Patients with higher income were more likely to receive tumour directed treatment, including curative intent treatment which may result in the observed longer survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands; Grow - School for Oncology and Deve…
- Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
- Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
- Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.
- Department of Pathology, Radboud University Medical Centre, Nijmegen, the Netherlands.
- Department of Surgery, Radboud University Medical Centre, Nijmegen, the Netherlands.
Zitieren
APA
Galanos, L. J. K., Elferink, M. A. G., Lurvink, R. J., Aarts, M. J., van Hellemond, I. E. G., Nagtegaal, I. D., de Wilt, J. H. W., De Hingh, I. H. J. T., & van Erning, F. N. (2026). Income, treatment patterns and outcome in patients with stage IV colorectal cancer. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116732
Vancouver
Galanos LJK, Elferink MAG, Lurvink RJ, Aarts MJ, van Hellemond IEG, Nagtegaal ID, et al. Income, treatment patterns and outcome in patients with stage IV colorectal cancer. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.116732
BibTeX
@article{Galanos2026,
author = {Galanos, Laskarina J K and Elferink, Marloes A G and Lurvink, Robin J and Aarts, Mieke J and van Hellemond, Irene E G and Nagtegaal, Iris D and de Wilt, Johannes H W and De Hingh, Ignace H J T and van Erning, Felice N},
title = {Income, treatment patterns and outcome in patients with stage IV colorectal cancer},
journal = {European Journal of Cancer},
year = {2026},
doi = {10.1016/j.ejca.2026.116732}
}
EUVIMED